| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.048 | 0.8 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |